|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2003-9-1
|
|
pubmed:abstractText |
Patients who have undergone resection for lymph node-positive esophageal squamous cell carcinoma are at high risk of recurrence and early death. The role of the postoperative adjuvant chemotherapy in this population needs to be determined. The present study was designed to determine whether the chemosensitivity test in fresh human esophageal squamous cell carcinoma, using highly purified tumor cells, correlates with the clinical response.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0022-4790
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright 2003 Wiley-Liss, Inc.
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
84
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
10-6
|
|
pubmed:dateRevised |
2006-4-24
|
|
pubmed:meshHeading |
pubmed-meshheading:12949985-Aged,
pubmed-meshheading:12949985-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:12949985-Carcinoma, Squamous Cell,
pubmed-meshheading:12949985-Chemotherapy, Adjuvant,
pubmed-meshheading:12949985-Cisplatin,
pubmed-meshheading:12949985-Disease-Free Survival,
pubmed-meshheading:12949985-Drug Administration Schedule,
pubmed-meshheading:12949985-Drug Screening Assays, Antitumor,
pubmed-meshheading:12949985-Epirubicin,
pubmed-meshheading:12949985-Esophageal Neoplasms,
pubmed-meshheading:12949985-Female,
pubmed-meshheading:12949985-Fluorouracil,
pubmed-meshheading:12949985-Humans,
pubmed-meshheading:12949985-Lymph Node Excision,
pubmed-meshheading:12949985-Lymph Nodes,
pubmed-meshheading:12949985-Lymphatic Metastasis,
pubmed-meshheading:12949985-Male,
pubmed-meshheading:12949985-Middle Aged,
pubmed-meshheading:12949985-Mitomycin,
pubmed-meshheading:12949985-Neoplasm Recurrence, Local,
pubmed-meshheading:12949985-Survival Analysis
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Clinical benefit of chemosensitivity test for patients with regional lymph node-positive esophageal squamous cell carcinoma.
|
|
pubmed:affiliation |
Second Department of Surgery, Wakayama Medical University, School of Medicine, Wakayama, Japan.
|
|
pubmed:publicationType |
Journal Article
|
